Concepedia

Kevin Dang

KD

Statistics

Publications

8

Citations

658

H-Index

8

Active since

2018

Affiliations

Tenneco (United States)(Current)

Mayo Clinic in Florida

Inserm

Nantes Université

University of California, San Francisco

Kevin Dang is an author at Tenneco (United States) specializing in immunology, life sciences, and oncology.

ORCID

Publications per year

2018–2022

8

Publications

8

CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels

Claudia C.S. Chini, Thais Peclat, Gina M. Warner et al. · Nature Metabolism · 2020 · 328 citations · Full text

, , +17

Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies

Nathan D. Trinklein, Duy Pham, Ute Schellenberger et al. · mAbs · 2019 · 103 citations · Full text

, , +17

Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release

Kevin Dang, Giulia Castello, Starlynn Clarke et al. · Journal for ImmunoTherapy of Cancer · 2021 · 73 citations · Full text

, , +17

Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies

Starlynn Clarke, Biao Ma, Nathan D. Trinklein et al. · Frontiers in Immunology · 2019 · 43 citations · Full text

, , +17

TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL

Harbani K. Malik-Chaudhry, Kirthana Prabhakar, Harshad S. Ugamraj et al. · mAbs · 2021 · 36 citations · Full text

, , +17

1–5 of 8